FDA Reapproves Wellcovorin for Cerebral Folate Deficiency
September 25, 2025
September 25, 2025
WASHINGTON, Sept. 25 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration is approving a previously withdrawn drug application for Wellcovorin (leucovorin calcium) tablets. This action will allow the drug to be used to treat symptoms in adults and children with cerebral folate deficiency (CFD).
The drug, which is manufactured by GlaxoSmithKline (GSK), London, United Kingdom, was first approved in 1983. Its approval was withdrawn in 1999 at the com . . .
The drug, which is manufactured by GlaxoSmithKline (GSK), London, United Kingdom, was first approved in 1983. Its approval was withdrawn in 1999 at the com . . .